Cargando…
Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases
Systemic rheumatic diseases are a heterogeneous group of autoimmune disorders that affect the connective tissue, characterized by the involvement of multiple organs, leading to disability, organ failure and premature mortality. Despite the advances in recent years, the therapeutic options for these...
Autores principales: | Rafael-Vidal, Carlos, Pérez, Nair, Altabás, Irene, Garcia, Samuel, Pego-Reigosa, Jose M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582977/ https://www.ncbi.nlm.nih.gov/pubmed/32993066 http://dx.doi.org/10.3390/ijms21197100 |
Ejemplares similares
-
Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis
por: Rafael-Vidal, Carlos, et al.
Publicado: (2021) -
Monocytes and Macrophages in Spondyloarthritis: Functional Roles and Effects of Current Therapies
por: Martínez-Ramos, Sara, et al.
Publicado: (2022) -
Semaphorin4A-Plexin D1 Axis Induces Th2 and Th17 While Represses Th1 Skewing in an Autocrine Manner
por: Carvalheiro, Tiago, et al.
Publicado: (2020) -
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
por: Schinocca, Claudia, et al.
Publicado: (2021) -
Serum Levels of IL-17 and IL-23 in Patients With Rheumatic Mitral Stenosis
por: Bilik, Mehmet Zihni, et al.
Publicado: (2016)